MODERN POTENTIAL IN THE TREATMENT OF METABOLIC SYNDROME PATIENTS - FOCUS ON ENDOTHELIUM

MODERN POTENTIAL IN THE TREATMENT OF METABOLIC SYNDROME PATIENTS - FOCUS ON ENDOTHELIUM

Numerous publications on the use of p-blockers in patients with arterial hypertension (AH) and metabolic syndrome (MS) have reported adverse effects of these medications on carbohydrate and lipid metabolism, as well as reduced cerebral perfusion. This review presents the benefits of a third-generati...

Full description

Saved in:
Bibliographic Details
Main Authors: V. B. Mychka, S. N. Tolstov, I. A. Salov, Yu. V. Prokhorova, E. I. Uzueva, A. L. Vertkin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2014-03-01
Series:Российский кардиологический журнал
Subjects:
metabolic syndrome
arterial hypertension
nitric oxide
p-blockers
nebivolol
Online Access:https://russjcardiol.elpub.ru/jour/article/view/26
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items